Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial

Br J Surg. 2023 Nov 9;110(12):1883-1884. doi: 10.1093/bjs/znad332.

Robert P Jones^{1

2}, Lennard Y W Lee³, Pippa G Corrie⁴, Sarah Danson⁵, Dale Vimalachandran^{1

6}

¹ Department of Molecular & Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
² Department of Hepatobiliary Surgery, Liverpool University Teaching Hospitals NHS Foundation Trust, Liverpool, UK.
³ Department of Oncology, University of Oxford, Oxford, UK.
⁴ Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁵ Department of Oncology, University of Sheffield, Western Bank, Sheffield, UK.
⁶ Department of Colorectal Surgery, Countess of Chester NHS Foundation Trust, Chester, UK.

No abstract available

Publication types